---
layout: post
title: "Photobiomodulation Devices-Premarket Notification Submissions; Draft Guidance for Industry and Food and Drug Administration Staff; Availability"
date: 2026-02-05 18:35:15 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2023-00422
original_published: 2023-01-12 00:00:00 +0000
significance: 8.00
---

# Photobiomodulation Devices-Premarket Notification Submissions; Draft Guidance for Industry and Food and Drug Administration Staff; Availability

**Published:** February 05, 2026 18:35 UTC
**Source:** Federal Register
**Original Published:** January 12, 2023 00:00 UTC
**Document Number:** 2023-00422

## Summary

The Food and Drug Administration (FDA or Agency) is announcing the availability of the draft guidance entitled "Photobiomodulation (PBM) Devices--Premarket Notification [510(k)] Submissions." This draft guidance provides recommendations on premarket submissions for photobiomodulation devices, which are used in applications such as aesthetics, dermatology, and other general indications. This draft guidance is not final nor is it for implementation at this time.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2023/01/12/2023-00422/photobiomodulation-devices-premarket-notification-submissions-draft-guidance-for-industry-and-food)
- API: https://www.federalregister.gov/api/v1/documents/2023-00422

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
